NCT03517566 - A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis | Biotech Hunter

Enrollment

293

Participants

Timeline

Start Date

November 14, 2018

Primary Completion Date

July 15, 2020

Study Completion Date

August 6, 2020

Conditions

Atopic Dermatitis

Interventions

DRUG

Placebo

once daily from baseline until week 16

DRUG

ZPL389 3mg

ZPL389 3 mg oral powder; once daily from baseline to week 16

DRUG

ZPL389 10mg

ZPL389 10 mg oral powder; once daily from baseline to week 16

DRUG

ZPL389 30mg

ZPL389 30 mg oral powder; once daily from baseline to week 16

DRUG

ZPL389 50mg

ZPL389 50 mg oral powder; once daily from baseline to week 16

Trial Locations (89)

201

Novartis Investigative Site, Kopavogur

3000

Novartis Investigative Site, Leuven

4032

Novartis Investigative Site, Debrecen

10002

Novartis Investigative Site, Taipei

11000

Novartis Investigative Site, Prague

20520

Novartis Investigative Site, Turku

20537

Novartis Investigative Site, Hamburg

22391

Novartis Investigative Site, Hamburg

29651

Novartis Investigative Site, Greer

30625

Novartis Investigative Site, Hanover

33520

Novartis Investigative Site, Tampere

33609

Novartis Investigative Site, Tampa

33612

Novartis Investigative Site, Tampa

33647

Novartis Investigative Site, Bielefeld

36001

Novartis Investigative Site, Karlovy Vary

38100

Novartis Investigative Site, Braunschweig

40201

Novartis Investigative Site, Taichung

40217

Novartis Investigative Site, Louisville

45231

Novartis Investigative Site, Cincinnati

45324

Novartis Investigative Site, Fairborn

48149

Novartis Investigative Site, Münster

49074

Novartis Investigative Site, Osnabrück

60590

Novartis Investigative Site, Frankfurt

69120

Novartis Investigative Site, Heidelberg

74101

Novartis Investigative Site, Nový Jičín

77004

Novartis Investigative Site, Houston

80337

Novartis Investigative Site, München

84088

Novartis Investigative Site, West Jordan

85101

Novartis Investigative Site, Bratislava

85340

Novartis Investigative Site, Litchfield Park

87700

Novartis Investigative Site, Memmingen

92103

Novartis Investigative Site, San Diego

92123

Novartis Investigative Site, San Diego

92708

Novartis Investigative Site, Fountain Valley

123182

Novartis Investigative Site, Moscow